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The initial interaction between mosquito-borne flavivirus West Nile and mosquito cells is poorly characterized. This study analyzed the
endocytic and the associated signaling pathway that mediate the infectious entry of West Nile virus (WNV) into mosquito cell line (C6/36).
Pretreatment of C6/36 cells with pharmacological drugs that blocks clathrin-mediated endocytosis significantly inhibited virus entry. Furthermore,
the transfection of functional blocking antibody against clathrin molecules and the overexpression of dominant-negative mutants of Eps15 in C6/
36 cells caused a marked reduction in WNV internalization. WNV was shown to activate focal adhesion kinase (FAK) to facilitate the endocytosis
of virus but not the mitogen-activated protein kinases (ERK1 and ERK2). Subsequent to the internalization of WNV, the virus particles are
translocated along the endosomal pathway as revealed by double-immunofluorescence assays with anti-WNV envelope protein and cellular
markers for early and late endosomes. Specific inhibitor for protein kinase C (PKC) was shown to be highly effective in blocking WNV entry by
inhibiting endosomal sorting event. The disruption of the microtubule network using nocodazole also drastically affects the entry process of WNV
but not the disruption of actin filaments by cytochalasin D. Finally, a low-pH-dependent step is required for WNV infection as revealed by the
resistance of C6/36 cells to WNV infection in the presence of lysosomotropic agents.
© 2006 Elsevier Inc. All rights reserved.Keywords: Flavivirus; Virus entry; Clathrin-mediated endocytosis; Endosome; CytoskeletonIntroduction
The entry process of virus into cells is often a complicated
process that involves virus binding to the surface of cells, entry
into the cytosol and transport of viral genome to appropriate site
for replication. The close association of virus with the host
cellular component is essential for the establishment of a
successful infection. Binding of virus to specific cellular
receptor(s) on the surface of cells can be triggered at least two
pathways that facilitate virus entry into cells. Some of the
viruses utilize receptor-mediated endocytosis and subsequent
acidification along the endo-lysosomal, which will trigger the
release of viral genome for replication (Sieczkarski and
Whittaker, 2005). This type of entry process has been shown
in both enveloped (influenza) and non-enveloped (adenovirus)⁎ Corresponding author. Fax: +65 7766872.
E-mail address: micngml@nus.edu.sg (M.L. Ng).
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doi:10.1016/j.virol.2006.01.022viruses (Lakadamyali et al., 2004; Meier and Greber, 2004).
Alternatively, other enveloped viruses are documented to fuse
with the host cellular membrane to gain access into the cells by
releasing the viral core into cytosol (Sieczkarski and Whittaker,
2005). Once the virus binds to the cellular receptor, it often
triggers a cascade of downstream signaling events that will
facilitate its entry process into cells and creating a suitable
environment for its subsequent replication (Pelkmans, 2005).
Therefore, understanding the fundamentals of the virus entry
process into host cells often provides opportunities for
intervention to help combat viral infections.
West Nile virus (WNV) is a medically important mosquito-
borne flavivirus that causes West Nile fever and meningo-
encephalitis (Hayes, 2005). It is a small-enveloped virus
classified as a member of the Japanese encephalitis virus
serocomplex of the genus Flavivirus in the family Flaviviridae
(Rice, 1996). The emergence of WNV in several parts of the
world has posed significant global health problem. WNV is
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cycle while mammals and human are often considered as
incidental or dead-end hosts (Campbell and Dreher, 2002). It
was speculated that the movement of WNV to the Western
Hemisphere was caused by migratory birds that acted as
introductory hosts and perhaps by infecting ornithophilic
mosquitoes (Rappole et al., 2000). WNV is transmitted to
vertebrate hosts mainly from the inoculation of virus harboring
mosquitoes of the Culex, Aedes, Anopheles, Minomyia and
Mansonia species in Africa, Asia and the United States (Burke
and Monath, 2001; Ilkal et al., 1997).
In our recent study, we have identified two putative receptor
molecules that are involved in the binding and entry process of
WNV (Chu et al., 2005) into susceptible C6/36 (Aedes
albopictus) cell line. However, little is currently known about
the entry process and pathway of WNV into mosquito cells.
Therefore, this is the first study that focuses on deciphering
WNV entry process into C6/36 cells. Understanding the
infection dynamics of WNV in mosquito cells can provide an
alternative means of anti-viral strategies that can act against the
infectious entry of WNV in mosquitoes.
Results
Infectious entry of WNV is inhibited by the disruption of
clathrin-mediated endocytosis
To investigate whether WNV entered mosquito cells by a
clathrin or caveola-dependent endocytosis pathway, the C6/36Fig. 1. Effects of receptor-mediated endocytosis disrupting drugs on WNV entry int
treatment time. C6/36 cells were treated with (a) monodanslycadervine, (b) chlorpro
significantly inhibited by monodanslycadervine, chlorpromazine and sucrose betw
Pretreatment for 1 h was equally effective except for filipin. The average of 3 indepmosquito cells were treated with a panel of compounds that are
known to selectively inhibit each of the specific pathways. C6/
36 cells were treated with monodanslycadervine (selectively
inhibit receptor-mediated endocytosis), chlorpromazine and
sucrose (inhibits clathrin-dependent endocytosis) and filipin
(inhibits caveola-dependent endocytosis by disrupting the
cholesterol-rich caveola-containing membrane microdomain)
and subjected to WNV infection (M.O.I. of 10). The
pretreatment as well as the administration of monodanslyca-
dervine (at 15 min p.i.) on C6/36 cells significantly inhibited
WNV infection by more than 75% (Fig. 1a). This result implied
that cellular receptor molecule(s) was involved in mediating the
internalization of WNV into C6/36 cells. In addition, the
pretreatment and the early administration (with 10 min p.i.) of
C6/36 cells with chlorpromazine (Fig. 1b) and sucrose (Fig. 1c)
also strongly inhibited WNV infection. It was noted that the
treatment of C6/36 cells with monodanslycadervine, chlor-
promazine and sucrose had minimal inhibitory effect on WNV
infection when these drugs were added after 1 h p.i. Therefore,
this may suggest that these drugs selectively exert their effects
in an early step of the virus entry pathway. In contrast, treatment
of C6/36 cells with filipin had no significant inhibitory effect on
WNV infection regardless of the timing of the administration of
this drug (Fig. 1d).
To affirm the involvement of clathrin-dependent endocytosis
pathway in mediating the entry of WNV into C6/36 cells,
molecular inhibitors in the form of dominant-negative mutants
of Eps-15 and arrestment of clathrin activities by specific
functional blocking antibodies were carried out. As ano C6/36 cells. The percentage of viral antigen positive cells was plotted against
mazine, (c) sucrose and (d) filipin. Endocytosis of WNV into C6/36 cells was
een 15 and 30 min p.i. whereas filipin has minimal effect on virus entry.
endent experiments is shown.
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endocytosis, the employment of dominant-negative mutants of
Eps-5 can be much more specific in targeting the arrestment of
clathrin-coated pit formation (Benmerah et al., 1999). GFP
tagged dominant negative mutant (GFP-EΔ95/295) and control
GFP-tagged constructs (GFP-D3Δ2 served as a negative
control and had no effect on clathrin-mediated endocytosis
(Querbes et al., 2004) and GFP served as an internal control)
were transiently transfected into C6/36 cells. Transfected cells
were then assayed for their capability to internalized Texas Red
(TR) conjugated transferrin (a specific marker for clathrin-
dependent endocytosis).Fig. 2. Dominant negative inhibitor of Eps15 inhibits WNVentry into C6/36 cells. (a
cells are transfected with GFP-EΔ95/295 construct (inhibit clathrin-dependent endo
have no effect on WNVentry into cells. The number of viral E antigen positive cells in
positive cells. (b–d) C6/36 cells was transfected with GFP-EΔ95/295, GFP-D3Δ2
detected with anti-WNV E protein antibody conjugated with TR. (b) Binding of WNV
EΔ95/295 with no internalization of virus particles was observed. (c and d) WNV is o
respectively.At 36 h posttransfection, maximal expression of the
transfected gene can be observed and the internalization of
TR-transferrin was impaired in cells transfected with GFP-
EΔ95/295. In contrast, the uptake of TR-transferrin was not
affected in cells expressing GFP-D3Δ2 or GFP (data not
shown). C6/36 cells were infected at the maximal expression of
the transfected gene and scored for virus infection. The
dominant negative mutant GFP-EΔ95/295 drastically inhibited
WNV infection by more than 85% but neither of the control
constructs exerted any inhibitory effect on WNV infection in
C6/36 cells (Fig. 2a). Fig. 2b shows the binding of WNVon the
surface of C6/36 cells expressing GFP-EΔ95/295 indicating) The infectious entry of WNV into C6/36 cells was significantly inhibited when
cytosis) whereas GFP-D3Δ2 and GFP constructs serve as negative control and
relation to the total cell population is expressed as a percentage of viral antigen-
and GFP constructs, respectively, and subjected to WNV infection. WNV was
(stained with TR) on the plasma membrane of C6/36 cells transfected with GFP-
bserved within the cytoplasm of C6/36 cells that expressed GFP-D3Δ2 and GFP,
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mediates entry of WNV into cells. In contrast, WNV was
observed within C6/36 cells expressing GFP-D3Δ2 or GFP
(Figs. 2c and d, respectively).
Previous studies have shown that microinjection of anti-
bodies against clathrin molecule into cells can effectively inhibit
the functional activities of clathrin in mediating endocytosis of
biomolecules (Wehland et al., 1982). In this part of the study, we
utilized the strategy of transfection to deliver functional
blocking antibodies against clathrin into C6/36 cells. To ensure
that the transfected antibodies were effective in inhibiting the
functional activity of clathrin, endocytosis of TR-transferrin
was first determined into C6/36 cells. Fig. 3a shows that
transfection of C6/36 cells with 25 μg of anti-clathrin antibody
can effectively inhibit the internalization of TR-transferrin
(arrows) when compared to cells not transfected with anti-
clathrin antibody (Fig. 3b). Transfection of anti-clathrin
antibody into C6/36 cells drastically reduced WNV infection
in a dosage-dependent manner (Fig. 3c). In contrast, WNV
infection was not affected when C6/36 cells were transfectedFig. 3. Transfection of functional blocking antibody against clathrin into C6/36 c
transferrin was inhibited in C6/36 cells transfected with anti-clathrin antibody. TR-tr
penetrate into the cells. (b) In contrast, TR-transferrin molecules are found within
infectious entry of WNV into C6/36 cells can be inhibited in a dose-dependent man
Transfection of anti-FITC antibody (▴) and an irrelevant antibody of the same isoty
antigen positive cells in relation to the total cell population is expressed as a percentag
shown.with control antibody of similar isotype or anti-FITC antibody
(Fig. 3c). These results together provided strong evidence that
clathrin-dependent endocytosis pathway is required for infec-
tious entry of WNV into C6/36 cells.
WNVactivates phosphorylation of focal adhesion kinase (FAK)
In our previous study, WNV was shown to bind to αVβ3
integrin and activates FAK for the internalized of WNV into
mammalian cells (Vero cell) (Chu and Ng, 2004b). The residue
Tyr397 of FAK has been shown in several studies to specifically
undergo autophosphorylation in response to the interaction of
ligands/virus and integrin at the focal adhesion sites (McLean et
al., 2000; Akula et al., 2002). The autophosphorylation of FAK
is also responsible for the outside-in signaling process to
mediate endocytosis of ligand/virus into cells. Although, it is
currently not known if integrin superfamily serves as the
functional receptor for WNV entry into C6/36 cells, we sought
to determine if FAK is being activated in C6/36 cells upon
exposure to WNV. Purified WNV was added to serum-starvedells inhibits WNV entry. (a) Clathrin-mediated endocytosis of TR-conjugated
ansferrin (arrows) is observed to bind to the surface of C6/36 cells but failed to
the cytoplasm of C6/36 cells transfected with an irrelevant antibody. (c) The
ner with the transfection of functional antibody against clathrin molecules (x).
pe and host origin (▪) did not affect the entry of WNV. The number of viral E
e of viral antigen-positive cells. The average of three independent experiments is
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immunodetection of the phosphorylation of FAK at appropriate
timing p.i. Phosphorylated FAK was not detected in serum-
starved cell lysate (Fig. 4a, lane 1). Induction of C6/36 cells
with 250 ng/ml LPA (positive control) resulted in FAK
phosphorylation within 3 min (Fig. 4a, lane 2). Phosphorylation
of FAK in WNV-infected cells was detected within 5 min after
adding the virus to C6/36 cells (Fig. 4a, lane 3) and was
sustained until 30 min after virus infection (Fig. 4a, lanes 4
and 5). Dephosphorylation of FAK was observed as infection
progressed from 45min p.i. (Fig. 4a, lane 6). To ensure that equal
amounts of cellular proteins were loaded into each of the wells,
the membrane was stripped and reprobed with antibody against
actin. Equal quantities of actin were observed throughout the
lanes (Fig. 4b). The effect of genistein (a specific inhibitor of
FAK) on WNVentry into C6/36 cells was determined by either
pretreatment or posttreatment of cells with the drug and
subjecting the cells to WNV infection. Previous study by
Mukhopadhyay et al. (2005) has shown that treatment of cells
with 60 μM of genistein can effectively inhibit the functional
activities of FAK. Pretreatment of C6/36 cells with genistein
significantly inhibits WNVentry into cells (Fig. 4c). In contrast,
genistein is less effective in inhibiting WNV replication when
the drug is added after virus entry into the C6/36 cells (Fig. 4c).
In addition, we also examined the activation of MAPKs
ERK1 and ERK2, as this pathway has previously been shown to
be activated in response to virus infection to create appropriate
intracellular environment to facilitate virus infection (QuerbesFig. 4. West Nile virus activates the integrin-dependent FAK but not ERK1/2. Activat
virus induces phosphorylation of FAK in C6/36 cells. Lane 1, serum-starved C6/36 c
200 ng/ml of LPA (positive control) for 5 min. Lane 3, C6/36 cells were infected withW
C6/36 cells were infected with WNV for 30 min. Lane 6, C6/36 cells were infected w
WNV infection and undergoes dephosphorylation after 45 min of WNV infection. (c
subjected to WNV infection. The percentage of viral antigen positive cells was plotted
(d) West Nile virus does not induce phosphorylation of ERK1/2 in C6/36 cells. Lane
cells were infected withWNV for 5 min. Lane 3, C6/36 cells were infected withWNV
36 cells were infected with WNV for 45 min. Lane 6, C6/36 cells were incuba
Autophosphorylation of ERK1/2 was not detected with infectious entry of WNV in
stripped and reprobed with antibody against actin to ensure equal amounts of cell lyet al., 2004). At appropriate timings after the addition of purified
WNV to serum-starved C6/36 cells, immunodetection of
activated ERK1/2 was carried out with an anti-ERK1/2
antibody against phosphorylated ERK1/2. As shown in Fig.
4d, ERK1/2 was not activated after the inoculation of C6/36 cell
with WNVover a period of 1 h (Fig. 4d, lanes 2–5). Activation
of ERK1/2 was induced with the addition of FCS (Fig. 4d, lane
6) and phosphorylated ERK1/2 was not detected in serum-
starved C6/36 cells (Fig. 4d, lane 1). Detection of actin was also
carried out to ensure that equal quantities of cellular proteins are
loaded throughout the lanes (Fig. 4e).
Trafficking of internalized WNV along endosomal pathway
We next asked whether WNV is translocated along the
endosomal–lysosomal pathway after clathrin-mediated endo-
cytosis to facilitate its subsequent replication process. Double
immunofluorescence was performed to track the localization of
WNV along the endosomal pathway for a period of 1 h p.i.
Antibodies specific for early endosomes (EEA1), late endo-
somes (MRP-1) and Lysotracker (specific staining dye for late
endosomes and lysosomes, Molecular Probes) were used to
identify the specific compartments involved in the translocation
of WNV.
To synchronize the entry process of WNV, C6/36 cells were
first incubated at 4 °C to allow for the attachment of WNVonto
the surface of cells but not the penetration of WNV into cells.
The cells were then warmed to 37 °C and processed for doubleion of FAK autophosphorylation in C6/36 cells upon virus binding. (a) West Nile
ells were not induced (negative control). Lane 2, C6/36 cells were induced with
NV for 5 min. Lane 4, C6/36 cells were infected with WNV for 15 min. Lane 5,
ith WNV for 45 min. Autophosphorylation of FAK is observed within 5 min of
) C6/36 cells were either pretreated or posttreated with 60 μM of genistein and
against treatment time. The average of three independent experiments is shown.
1, serum-starved C6/36 cells were not induced (negative control). Lane 2, C6/36
for 15 min. Lane 4, C6/36 cells were infected with WNV for 30 min. Lane 5, C6/
ted with culture medium containing 10% FCS (positive control) for 5 min.
to C6/36 cells. (b and e) The membranes from panels a and d, respectively, are
sate were loaded in each of the wells.
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were warmed to 37 °C, C6/36 cells were fixed and processed for
immunofluorescence staining, WNV can be observed to
localize predominantly on the surface of C6/36 cells. At 5
min after the cells were warmed to 37 °C, WNV can be
observed in numerous of early endosomes as indicated by the
colocalization (yellow staining) of TR-conjugated anti-WNV
antibody (red) and FITC-conjugated anti-EEA1 antibody
(green) (Fig. 5a). From 10 to 15 min, WNV can be detected
within late endosomes as indicated by the immunolabeling of
these vesicles with anti-MRP1. By 20 min after a shift up to
37 °C, WNV is localized predominantly within vesicles that are
stained by Lysotracker, indicating that WNV can be found
within both late endosomes and lysosomes.
Cellular fractionation in 20% Percoll gradient was further
performed to confirm the distribution of WNV in specific
location in the entry process. Cellular fractionation in a 20%
self-generated Percoll gradient allowed the separation of
subcellular particles based on buoyant density. Density marker
beads (Amersham Pharmacia) were used as external markers to
facilitate the density measurement of the separated subcellularFig. 5. Localization of WNV within endocytic vesicles. (a) At 5 min p.i., WNV part
(stained green with anti-EEA1) in C6/36 cells. (b and c) WNV (red) are localized wit
(d) At 20 min p.i., WNV can be observed within late endosomes as well as lysosomes
endocytic vesicles can be observed as yellow speckles in the superimposed images. NU
figure legend, the reader is referred to the web version of this article.)particles in the gradient. The densities of the endosomes,
lysosomes, plasma membrane and endoplasmic reticulum were
predetermined and were determined to be 1.034, 1.075, 1.045
and 1.058 g/ml, respectively (data not shown). In this part of the
experiment, C6/36 cells were incubated with 35S-radiolabeled
WNV at an M.O.I. of 10 at 4 °C for 30 min. At the appropriate
timings upon warming to 37 °C, the WNV-infected cells were
subjected to homogenization and fractionation in a Percoll
gradient. A total of 24 fractions were collected and analyzed for
radioactivity counting. The densities of the radioactive peaks
were determined relative to the density bead markers based on
their positions in the Percoll gradient as shown in Fig. 6a. A
single peak of radioactivity counts was detected and the density
of this peak corresponded to that of the plasma membrane
fraction (1.045 g/ml) when cells incubated with WNV at 4 °C
for 30 min were subjected to cellular fractionation (Fig. 6b),
hence, indicating the attachment of WNV to the plasma
membrane of C6/36 cells. At 10 min upon warming to 37 °C,
two peaks of radioactivity peaks were determined (Fig. 6c). The
density of the first peak corresponded closely to the endosome
marker fraction (1.034 g/ml), whereas the second peak was inicles (stained red with anti-WNV E protein) are localized with early endosomes
h late endosomes (stained green with anti-MRP) for a period of 10 to 15 min p.i.
as indicated by lysostracker. The localization of WNV within different forms of
denotes nucleus of the cell. (For interpretation of the references to colour in this
Fig. 6. Subcellular fractionation of cellular homogenates from WNV-infected cells in 20% Peroll gradients. (a) Standard plot of density distribution determined by
densitymarker beads in the 20%Percoll gradient. (b) C6/36 cells are allowed to bind 35S-radiolabeledWNVat anM.O.I. of 10 for 30min at 4 °C and subjected to cellular
fractionation.WNVis detected predominantly in association with the plasmamembrane fraction. (c and d) A procedure similar to that for panel b was carried out except
that the C6/36 cells were incubated at 37 °C for a period of 10 min and 20 min, respectively. Trafficking of the WNV particles along the endocytic pathway was noted.
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(1.075 g/ml). Since, the first peak had a much higher
radioactivity counts when compared to that of the second
peak, it suggested that majority of the virus particles were
localized within the early endosomes at this timing p.i. By 20
min, three radioactivity count peaks were obtained. The
densities of the 3 peaks corresponded to the early endosomes,
the endoplasmic reticulum and the late endosome/lysosome
markers, respectively (Fig. 6d). The radiolabeled WNV was
observed to localize predominantly within the late endosome/
lysosome fraction (with the highest radioactivity counts).
Translocation of the uncoated WNV (virus nucleocapsid
enclosing viral RNA) to the ER for virus replication could
contribute to the radioactivity peak observed in the ER density.
Therefore, the results obtained from both immunofluorescence
assays and cellular fractionation analyzes illustrated the
translocation of WNV particles along the endosomal–lysosom-
al pathway subsequent to endocytosis from the cell surface.
Role of cytoskeleton network in the entry pathway of WNV
The possible involvement of the host cellular cytoskeleton
network, namely the actin filaments and the microtubules in the
endocytosis pathway of internalized WNV, was investigated
too. C6/36 cells were first pretreated with cytoskeleton-
disrupting drugs, cytochalasin D and nocodazole that act
specifically by inducing depolymerization of actin filaments
and the microtubule network, respectively. The concentration of
the cytochalasin D and nocodazole used in this part of theexperiment was predetermined to be non-cytotoxic but effective
in disrupting the functional activities of the actin and
microtubule network (data not shown). Cells were assayed for
infectious entry of WNV by counting the number of viral E
protein antigen positive cells. Treatment of C6/36 cells with
increasing concentration of nocodazole revealed a dosage-
dependent inhibition of WNV infection (Fig. 7a). In contrast,
cytochalasin D had minimal inhibitory effect on WNV infection
(Fig. 7b). With increasing concentration of cytochalasin D, the
percentage of viral antigen positive cells remained relatively
constant at 85%. Therefore, these results provided evidence that
the integrity of the microtubule network was essential for the
entry of WNV but less so for the actin filaments.
Inhibition of PKC affects WNV entry into C6/36 cells
The role of PKC in the endocytosis of WNV into C6/36 cells
was also assessed. Several studies have documented that PKC
plays an important role in regulating the receptor-mediated
endocytosis of virus–receptor complexes; promoting endo-
some–endosome fusion as well as the trafficking of internalized
virus along endosomal–lysosomal pathway (McClure and
Robinson, 1996; Nakano et al., 2000; Sieczkarski et al., 2003).
C6/36 cells were treated with bisindolymaleimide (BIS) before
subjecting the cells for WNV infection. BIS is a new generation
of PKC inhibitor and is highly specific by blocking the catalytic
domain of PKC. BIS is also capable of inhibiting all PKC-
isoforms with similar potency (Toullec et al., 1991). Fig. 8a
shows that pretreatment of C6/36 cells with increasing non-
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significantly. To define the specific site(s) whereby BIS acts to
inhibit WNV entry pathway, cellular fractionation of radio-
labeled WNV-infected C6/36 cells (pretreated with 5 μg/ml
concentration of BIS) was performed over a time period of 30
min. At 15 min p.i., only a single peak of radioactivity was
detected (Fig. 8b) and this peak remained in the same density
fraction throughout the study till 30 min p.i. (Fig. 8c). This
specific peak corresponded to the early endosome fraction.
Hence, BIS acts on PKC by inhibiting the trafficking of the
internalized WNValong the endosomal pathway.
Low pH-dependent entry of WNV
To examine pH-dependent entry of WNV, C6/36 cells were
pretreated with lysosomotropic weak bases (chloroquine) and
vacuolar H+-ATPase (VATPase) inhibitor (bafilomycin A).
Lysosomotropic weak bases act by raising the pH within acidic
vesicles and thus function as a proton sink. Bafilomycin A is a
potent and specific inhibitor of VATPase that inhibits endosome
and lysosome acidification (Yoshimori et al., 1991). The
effective concentration of the drugs to inhibit acidification of
vesicles was first assayed by staining intracellular acidic
vesicles with acridine orange. To analyze the effect of
chloroquine and bafilomycin A on the entry mechanism of
WNV, C6/36 cells were pretreated with increasing non-
cytotoxic concentrations of each drugs, followed by WNVFig. 8. PKC inhibitor disrupts endocytic trafficking of internalized WNV
particles. (a) Pretreatment of C6/36 cells with bisindolylmaleimide (BIS)
drastically inhibits entry of WNV in a dosage-dependent manner. Bisindolyl-
maleimide-pretreated C6/36 cells are subjected to cellular fractionation after
incubation with 35S-radiolabeled WNVat an M.O.I. of 10 for (b) 15 min and (c)
30 min, respectively. Only a single radioactivity peak that corresponded to the
early endosomal fraction was detected in both the samples.
Fig. 7. Effects of cytoskeletal disrupting drugs on the entry of WNV into C6/36
cells. The percentage of viral antigen-positive cells is plotted against
concentrations of drugs used. There is a dose-dependent inhibition of WNV
internalization into (a) nocodazole-treated cells but not for (b) cytochalasin D-
treated C6/36 cells. The average of three independent experiments is shown.infection. Both chloroquine and bafilomycin A effectively
inhibited WNV infection (Figs. 9a and b, respectively),
suggesting that the infectious entry of WNV required a low
pH-dependent step in the endocytic pathway. Minimal cell
toxicity was observed in drug-treated cells throughout the
spectra of concentrations used in this experiment.
Discussion
Little attention is currently given to understand the interaction
of mosquito-borne flaviviruses with mosquito cells. WNV has
been isolated from Culex, Aedes, Anopheles, Minomyia and
Mansonia mosquitoes (Burke and Monath, 2001; Ilkal et al.,
1997). To better understand the replication cycle of mosquito-
borne flaviviruses in mosquito cells, a number of mosquito
Fig. 9. Low pH-dependent entry of WNV into C6/36 cells. Inhibitory effect on
the entry of WNV into pretreated C6/36 cells with (a) chloroquine or (b)
bafilomycin A. A dose–response inhibition of WNV entry was observed. The
percentage of viral antigen-positive cells is plotted against concentrations of
drugs used. The average of three independent experiments is shown.
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et al., 2004). The ability of flavivirus to infect a cell line derived
from a particular arthropod vector can reflect the natural vector–
virus relationships (Lawrie et al., 2004; Mussgay et al., 1975),
thus providing information about virus transmission and viral
persistence in the natural environment. In this study, we utilized
the A. albopictus cell line (C6/36) that has been shown to be
highly susceptible to WNV infection (Turell et al., 2001a,
2001b), to investigate the entry process of WNV into mosquito
cells. For the first time, we document here that clathrin-mediated
endocytosis and the activation of integrin-associated focal
adhesion kinase signaling were necessary for WNV infectious
entry into C6/36 mosquito cells.
A number of cellular molecules have been shown to facilitate
the binding and entry of mosquito-borne flaviviruses into
different mammalian cells, these include glycosaminoglycans,
DC-SIGN, laminin receptor, BiP, αVβ3 integrin, Hsp70 and
Hsp90 (Chu and Ng, 2004b; Chen et al., 1997; Navarro-
Sanchez et al., 2003; Tassaneetrithep et al., 2003; Jindadam-
rongwech et al., 2004; Thepparit and Smith, 2004; Reyes-Del
Valle et al., 2005). Recently, αVβ3 integrin was documented to
serve as the functional receptor to mediate WNV entry into
mammalian cells (Chu and Ng, 2004b). By using virus overlay
protein blot assay, we have recently identified two putative
plasma membrane-associated proteins (95 kDa and 70 kDa)
from C6/36 cells that may function as the cellular receptorcomplexes to mediate entry of WNV (Chu et al., 2005).
Monodansylcadaverine is known to have potent anti-viral
activity by preventing virus–receptor-mediated endocytosis and
virus clustering in coated pits hence preventing virus entry
(Schlegel et al., 1982). Consistent with this documentation, the
entry of WNV into C6/36 cells was effectively blocked with
monodansylcadaverine (Fig. 1a). Hence, these results indicated
the involvement of specific cellular receptor molecules that
facilitated the entry of WNV into mosquito cells.
Subsequent to the initial interaction of ligand/virus with the
cellular receptor, an internalization signal is usually triggered to
facilitate the endocytosis of the ligand/virus into cells
(Sieczkarski and Whittaker, 2005). Binding of WNV to C6/36
cells was observed to activate FAK (the integrin-linked kinase
responsible for the central paradigm of outside-in signaling) by
inducing auto-phosphorlyation. The activation of FAK was
similarly observed in mammalian cells upon WNV binding to
the cellular receptor, αVβ3 integrin (Chu and Ng, 2004b).
Therefore, it seems that the activation of FAK during WNV
entry process was conserved in both mammalian and mosquito
cells. It is currently not known if integrin superfamily may
function as cellular receptor in C6/36 cells for WNV. However,
there is a high possibility that integrin molecule may function as
the cellular receptor in C6/36 cells since the FAK outside-in
signaling pathway is highly integrin-specific. Further investiga-
tions are currently being carried out to address this issue.
The auto-phosphorlyation of FAK is important for the
formation of phosphotyrosine docking sites for several classes
of signaling molecules (Greber, 2002; Parsons, 2003) and is
necessary for the endocytosis of the WNV into cells. In turn,
phosphorylated FAK can activate a network of integrin-
stimulated signaling pathways leading to the activation of
targets such as the ERK and JNK/mitogen-activated protein
kinase pathways (Schlaepfer et al., 1999; Campbell and Dreher,
2005). These cellular signaling pathways can serve to promote
appropriate intracellular environment for virus internalization,
trafficking and replication. In this study, ERK was not activated
in C6/36 cells upon WNV infection, hence ruling out the
important role of ERK in mediating WNV infection. A recent
study by Mizutani et al. (2003), however, showed the
involvement of JNK pathway in the endocytosis of WNV into
mosquito cells. Therefore, these observations supported the
notation that binding of WNV to cellular receptor(s) on C6/36
cells caused phosphorylation of FAK and subsequently
activated the JNK pathway instead of ERK pathway for virus
entry and replication.
Although the involvement of clathrin-mediated endocytosis
pathway is well documented in the entry of numerous viruses
into mammalian cells, to date no study has been carried out to
investigate this endocytosis pathway in mosquito cells. We next
used pharmacological agents (chlorpromazine, sucrose and
filipin) to ask whether the endocytosis of WNV into C6/36 cells
occurred via clathrin-dependent or caveola-dependent pathway.
Chlorpromazine is a cationic amphiphilic drug that prevents
recycling of clathrin by accumulating clathrin and AP-2 in
endosomal compartments, hence preventing clathrin-dependent
endocytosis (Wang et al., 1993). The induction of hypertonicity
472 J.J.H. Chu et al. / Virology 349 (2006) 463–475and depletion of potassium ions by high concentration of
sucrose can also arrest the formation of functional clathrin-
coated pits for endocytosis (Brodsky et al., 2001). Chlorprom-
azine and sucrose have been widely utilized to analyze the
involvement of clathrin-dependent endocytosis of ligands and
viruses. The pretreatment as well as the early treatment (within
15 min p.i.) of C6/36 cells with non-cytotoxic concentrations of
chlorpromazine and sucrose drastically reduced WNV infection
(Fig. 1). In contrast, filipin treatment (which inhibits caveola-
dependent endocytosis) of C6/36 cells had minimal effect on
inhibiting WNV infection (Fig. 1).
Eps15 is an important accessory factor that regulates
clathrin-mediated endocytosis. The overexpression of dominant
negative mutants of Eps15 could strongly pertubate clathrin-
dependent endocytosis (Carbone et al., 1997; Benmerah et al.,
1998). The expression of dominant negative mutant of Eps15
(GFP-EΔ95/295) prevented WNV internalization into C6/36
cells but not affecting virus binding to the surface of the cells
(Fig. 2). In addition, transfection of increasing concentrations of
antibodies against clathrin also arrested the clathrin-dependent
endocytosis of WNV into C6/36 cells (Fig. 3).
Structural and molecular modeling studies have shown the
importance of low pH-dependent irreversible trimerization of
flavivirus envelope protein to expose the fusion peptide and
allows for membrane fusion with endocytic compartments
(Bressanelli et al., 2004). This is essential for the release of
internalized virions within endocytic compartments into the
cytoplasm for replication (Chu and Ng, 2004a; Modis et al.,
2004; Stiasny et al., 1996). In this study, WNV was observed
within early endosomes and subsequently translocated to the
late endosomes by 15 min p.i. The requirement of low pH
environment for the uncoating process of WNV was further
confirmed with lysosomotrophic weak bases (chloroquine) and
vacuolar H+ ATPase inhibitor (bafilomycin) that markedly
reduced WNV infection in treated C6/36 cells (Fig. 9).
Therefore, the entry process of WNV into C6/36 cells is much
similar to that of the mammalian cells as previously documented
by Chu and Ng (2004a).
Despite much similarities of the WNV entry process into
the mosquito cells when compared with the vertebrate system,
there is a difference in the involvement of the cytoskeletal
network. In our previous study, the actin filaments were
shown to be involved in mediating the internalization of
WNV particles into mammalian cells by clathrin-dependent
endocytosis (Chu and Ng, 2004a). In contrast, this study
showed that the disruption of actin filaments by cytochalasin
D treatment had little effect on the entry process of WNV into
C6/36 cells. Similarly, Mizutani et al. (2003) have also noted
that the disruption of actin filaments before subjecting the
cells for virus infection did not affect the productive yield of
WNV. One possible explanation is that the actin filaments in
mosquito cells are not essential in mediating clathrin-
dependent endocytosis of WNV into the cells. Future studies
are required to decipher this unknown mechanism. However,
the perturbation of the microtubule network drastically
reduced the infectious entry of WNV into C6/36 cells (Fig.
7) by affecting the endosomal trafficking.To our knowledge, this is the first representative study that
analyzed the detail entry pathway of a mosquito-borne
flavivirus (WNV) into mosquito cells even though extensive
studies on the entry mechanism of mosquito-flaviviruses
(Dengue, kunjin and Japanese encephalitis and West Nile
virus) have been carried in the mammalian counterpart (Gollins
and Porterfield, 1985; Ng and Lau, 1988; Nawa et al., 2003;
Chu and Ng, 2004a,b). It seems that the clathrin-mediated
endocytosis followed by the low pH-dependent membrane
fusion during WNV entry is conserved in both vertebrate and
invertebrate host. Therefore, understanding the initial but
crucial step in the flavivirus replication cycle can facilitate the
future development of anti-viral strategies as well as vector
control strategies to combat this re-emerging medically
important virus. Bioengineering of mosquito vectors that are
resistant to WNV infection by blocking the entry process can be
achieved. Several studies are being carried out to molecularly
engineer mosquito that is resistant to arthropod-borne viruses
(yellow fever virus and California serogroup virus) (Higgs et al.,
1998; Powers et al., 1996). Subsequent release of these
genetically engineered virus-resistant mosquitoes can serve as
an alternative anti-viral strategy to control the transmission of
these viruses.
Materials and methods
Maintenance of cell lines and virus preparation
C6/36 cells, a continuous mosquito cell line (kindly provided
by Professor Akira Igarashi, Japan) derived from A. albopictus
(Diptera: Culicidae) embryonic tissue, were grown in L-15
medium (GIBCO) containing 10% heat-inactivated fetal calf
serum (FCS) at 28 °C. Vero cells (green monkey kidney cells,
America Type Culture Collection) were maintained at 37 °C in
Medium 199 (M199; GIBCO) containing 10% inactivated FCS.
West Nile virus (strain Sarafend) used in this study was kindly
provided by Professor Edwin Westaway, Australia and the virus
was propagated in C6/36 cells throughout this study.
Confluent monolayers of C6/36 cells were infected with
WNV at a multiplicity of infection (M.O.I.) of 10. For
preparation of radiolabeled WNV, at 10 h p.i., cells were
starved in methionine-free medium for 2 h and the medium was
then replaced by 0.5% FCS-L-15 media containing L-[35S-
methionine, 10 μCi/ml] and 2 μg/ml actinomycin D (Sigma,
USA). At 48 h p.i., the infected cell culture supernatant (labeled
or non-labeled virus) was harvested. The infected cell culture
supernatant was centrifuged at 5000 rpm for 10 min to remove
cell debris before the virus was concentrated and purified. West
Nile virus was first concentrated and partially purified by using
a centrifugal filter device (Millipore, Bedford) at 2000 rpm for 2
h. The partially purified viruses were then applied onto a 5 ml
25% sucrose cushion for further purification. Sucrose gradient
was centrifuged at 25,000 rpm for 2.5 h at 4 °C in a SW55 rotor.
Finally, the purified virus pellet was resuspended in TNE buffer
(50 mM Tris–HCl, 100 mM NaCl, 1 mM EDTA, pH 7.2). The
resuspended virus was aliquoted, snapped frozen and stored at
−80 °C. Quantification of the viruses was performed on Vero
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activity of the radiolabeled virus preparation were approxi-
mately 6 × 108 PFU/ml and 1 × 104 cpm/ml, respectively.
Antibodies and reagents
Mouse monoclonal antibodies against WNV (H546) were
purchased from Microbix Biosystems, Inc. The antibody for
WNV E protein was a monospecific polyclonal antibody, kindly
provided by Vincent Deubel, Pasteur Institute, Paris, France.
Mouse monoclonal antibodies to cellular proteins, clathrin,
early endosomal antigen 1 (EEA1), mannose-6-phosphate
receptor (MPR) and lysosomal-associated membrane protein 1
(LAMP1) were purchased from BD Pharmingen. The secondary
antibodies conjugated to Texas red (TR) or fluorescein
isothiocyanate (FITC) were purchased from Amersham Phar-
macia Biotech. Lysotracker (a stain for late endosomes and
lysosomes) was purchased from Molecular Probes. Monodan-
slycadervine, chlorpromazine, filipin, nocodazole, cytochalasin
B, bafilomycin A, chloroquine and bisindoylmaleimide (BIS)
were purchased from Sigma.
Indirect immunofluorescence microscopy
For immunofluorescence microscopy, C6/36 cell mono-
layers were first grown on coverslips until 75% confluency. The
subsequent procedure is similar to that described in Chu and Ng
(2002). The primary antibodies to EEA1, MPR and LAMP1
were used at concentrations of 0.30 μg/ml and 0.2 μg/ml for
anti-WNV antibodies. Texas-Red or FITC-conjugated second-
ary antibodies were used at a concentration of 0.1 μg/ml. The
specimens were then viewed with a laser scanning confocal
inverted microscope (Leica TCS SP2) with an excitation
wavelength of 543 nm for TR and 480 nm for FITC by using
a ×63 objective lens.
Transfection of vectors and antibodies into cells
Plasmid constructs of Eps15 (GFP-EΔ95/295-dominant-
negative and GFP-D3Δ2) were kindly provided by A.
Benmerah, Pasteur Institute, and plasmid constructs backbone
EGFP-C2 was purchased from Clontech. Transfection of Eps15
plasmid constructs into C6/36 cells was performed as
essentially described in Chu and Ng (2004a) by using
Lipofectamine Plus reagents from Invitrogen. In brief, C6/36
cells were grown on coverslips in 24-well tissue culture plate
until 75% confluency. Then, 2.5-μg portions of the respective
constructs were complexed with 4 μl of Plus reagent in 25 μl of
OPTI-MEM medium (Gibco) for 15 min at room temperature.
The mixture was then added to 25 μl of OPTI-MEM containing
2 μl of Lipofectamine. After incubation for another 15 min, the
DNA–liposome complexes were added to the cells. After
incubation for 8 h at 28 °C, 1 ml of complete growth medium
was added and incubated for another 24 h before virus entry
assay was carried out.
Transfection of antibodies into cells was performed using
ProTrans reagent from MoBitec Gmbh (Germany) as specifiedby the manufacturer. In brief, C6/36 cells were first grown on
coverslips in 24-wells tissue culture plate until 75% confluency.
Antibodies (50 to 100 μg/ml) were first prepared in PBS and 40
μl of the antibodies was added to hydrate one QuickEase tube
containing the dried ProTrans reagent. The mixture was allowed
to stand at 25 °C for 5 min and followed by the addition of 500
μl of serum-free cell culture medium. The cell monolayer was
washed thrice with PBS before adding the transfection
complexes to the cells. The cells were incubated for 8 h at 28
°C. After incubation, the cells were replaced with L-15
containing 10% inactivated FCS. The transfection efficiency
was checked by immunofluorescence assay and the transfected
cells were used for subsequent experiments.
Percoll fractionation of cell homogenates
C6/36 cells were infected with 35S-labeled WNVat an M.O.
I. of 10 for 1 h at 4 °C. Unbound virus was removed by two
washes with phosphate-buffered saline (PBS). The cells were
then allowed to internalize WNV for 5, 10, 15 and 30 min at 37
°C. At appropriate times after internalization of virus particles,
the cells were washed twice with cold PBS before being
detached by gentle scraping. After centrifugation for 10 min at
1500 rpm, the cell pellet was resuspended in homogenization
buffer (10 mM Tris–HCl, 0.2 mM sucrose, 1 mM EDTA,
protease cocktail inhibitor [pH 7.4]). The suspension was
subjected to 15 strokes in a tight-fitting homogenizer (Jensons).
The homogenate was centrifuged for 10 min at 1000 rpm (to
remove the nuclei), and the postnuclear supernatant was
collected. For the separation of subcellular particles in the
postnuclear supernatant, an isosmotic solution of 20% Percoll
was prepared as previously described (Chu and Ng, 2004a). The
postnuclear supernatant samples were centrifuged at 32,000 × g
for 30 min in a Beckman 70.1 Ti rotor. Density marker beads
(Pharmacia Biotech) were used as external standards for the
density gradients in the Percoll solution. Cellular fractions of
250 μl were collected and processed for liquid scintillation
counting of 35S-labeled WNV radioactivity in a Beckman
LS6500 liquid scintillation counter.
Virus entry assay and drugs treatments
C6/36 cells growing on coverslips were incubated with
WNV at an M.O.I. of 10 for 1 h at 4 °C with gentle rocking.
Unbound virus was washed three times in ice-cold PBS and
shifted to 37 °C for 1 h in growth medium to allow virus
penetration. Extracellular virus that failed to enter into cells was
inactivated with acid glycine buffer (pH 2.8). Infected
monolayers were washed twice with PBS and further incubated
at 28 °C for 48 h. At 2 day p.i., cells were fixed in methanol and
processed for immunofluorescence assay as described above.
The number of infected cells is scored in comparison to mock-
infected cells.
To determine the effects of the drugs used to inhibit the
infectious entry of WNV, C6/36 cells were either pretreated with
drugs (as listed below) for 30 min at 28 °C followed by virus
infection, or the drugs were added at 10 min, 30 min, 1 h or 2
474 J.J.H. Chu et al. / Virology 349 (2006) 463–475h p.i. Cells were infected as described above and processed for
immunofluorescence assay. Three independent experiments
were carried out for each set of drugs used. The inhibition of
virus entry was assessed by determining the number of virus
antigen-positive cells in relation to the total number of cells
(virus antigen positive and negative) and is expressed as the
percentage virus antigen-positive cells.
The drugs used in the present study were as follows:
inhibitor of receptor-mediated endocytosis, monodanslycader-
vine (0.5 mM); inhibitors of clathrin function, chlorpromazine
(5 μg/ml) and sucrose (0.3 M); inhibitor of caveola-dependent
endocytosis, filipin (1 μg/ml); focal adhesion kinase inhibitor,
genistein (60 μM), lysosomotropic drug, chloroquine (40–140
μM); vacuolar-ATPase inhibitor, bafilomycin A1 (10–30
μM); inhibitor of the endocytotic trafficking pathway,
cytochalasin B (0.5–2.5 μg/ml) and nocodazole (5–40 μM);
and protein kinase C inhibitor, bisindolylmaleimide (0.5–10
μg/ml). The cytotoxicity of the drugs on cells was assessed
by the CytoTox 96 non-radioactive cytotoxicity assay
(Promega, USA) following the instructions stated by the
manufacturer.
Detection of focal adhesion kinase (FAK)/mitogen-activated
protein kinase (ERK) activation by Western blot analysis
C6/36 cells grown in six-well plates were serum-starved for
12 h in L-15 medium. Cells were washed twice with PBS and
purifiedWNV (M.O.I. of 10) was added to the cells at 4 °C for 30
min. The incubation temperature was shifted to 37 °C to allow
virus entry for a period of 0 to 30 min. The virus-infected cells
were then washed in cold PBS and lysed in ice-cold lysis buffer
(150 mM NaCl, 0.1% SDS, 1% Triton X-100, 0.4 mM
phenylmethylsulfonyl fluoride and 0.8% sodium deoxycholate
in 0.01 M Tris–HCl, pH 7.4). The cell lysate was spun at
1000 × g for 5 min to remove the nuclei followed by SDS-PAGE
and Western blotting. The activation of FAK, ERK1 or ERK2
was detected using antibody specific for the phosphorylated
residue Tyr397 of FAK and Thr202/Tyr204 of ERK1/2
respectively.
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